When was Tvardi Therapeutics, Inc. stock made available for the first time to the public?

The IPO Date for Tvardi Therapeutics, Inc. is 2025-04-16. On this 2025-04-16, Tvardi Therapeutics, Inc. stock was made publicly available.

Where is the headquarters of Tvardi Therapeutics, Inc. stock?

Headquarters of Tvardi Therapeutics, Inc. is in US at 2450 Holcombe Blvd, Suite X, Sugar Land, TX 77021.

What industry does Tvardi Therapeutics, Inc. belong to?

The Tvardi Therapeutics, Inc. belongs to Biotechnology.

Tvardi Therapeutics, Inc.

TVRD•NASDAQ

Healthcare

Biotechnology

$26.50

$4.37(19.75%)

Tvardi Therapeutics, Inc. (TVRD) Company Profile & Overview

Explore Tvardi Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Tvardi Therapeutics, Inc. (TVRD) Company Profile & Overview

Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. Their lead candidate, TTI-101, is currently in Phase 2 clinical trials for idiopathic pulmonary fibrosis (IPF) and hepatocellular carcinoma (HCC).

SectorHealthcare

IndustryBiotechnology

CEOImran Alibhai

Contact Information

https://tvarditherapeutics.com BioSpace +4

832-413-1362

2450 Holcombe Blvd, Suite X, Sugar Land, TX, 77021

Company Facts

17 Employees

IPO DateApr 16, 2025

CountryUS

Actively Trading

Frequently Asked Questions

;